Carrie Mills

Carrie L. Mills serves as a procurement specialist responsible for managing complex acquisitions in the life sciences and advanced analytical instrumentation sectors. She plays a pivotal role in aligning agency requirements with federal contracting regulations, ensuring compliance with FAR provisions while advancing mission-critical research and manufacturing capabilities. Her portfolio primarily encompasses research and development services, pharmaceutical production, and laboratory equipment procurement, supporting scientific innovation and public health objectives. Mills is deeply engaged in the full acquisition lifecycle—from market research and solicitation development to contract award and performance monitoring—ensuring technical rigor and regulatory adherence across all procurements. Her contractor relationships center on mid- to large-scale firms with proven expertise in biotechnology R&D, pharmaceutical manufacturing, and precision instrument design. She routinely engages with vendors possessing cGMP certification, ISO 13485 compliance, and FDA-regulated experience, fostering partnerships grounded in quality assurance and regulatory alignment. While no single contractor dominates her portfolio, she consistently collaborates with specialized firms capable of delivering high-complexity, low-volume solutions requiring stringent documentation and validation protocols. Mills demonstrates a strong commitment to small business participation, with 30% of her acquisitions structured as total small business set-asides under FAR 19.5. Her contracting patterns reflect a deliberate preference for non-set-aside procurements when full and open competition best serves technical needs, yet she actively promotes small business inclusion through targeted market engagement and clear solicitation language that encourages SB participation. She does not prioritize 8(a), HUBZone, or SDVOSB set-asides, instead favoring broad small business eligibility under the standard 19.5 framework. Her primary technical focus lies in NAICS 541714 (biotechnology R&D) and 325412 (pharmaceutical preparation), with additional emphasis on analytical instrument manufacturing (334516) and specialized scientific services (541990). She procures everything from preclinical research platforms and GMP-grade drug formulation systems to mass spectrometers and chromatography instrumentation, demonstrating deep domain knowledge in life sciences infrastructure and laboratory automation.